Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

Bain Capital already owns nearly 40 percent of the Tennessee-based company’s stock. An analyst thinks other potential buyers ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Surgery Partners has received an acquisition offer the could take the public company private. Boston-based Bain Capital Partners has made an offer to purchase all outstanding shares of the company for ...

As multiple media reported, Bain Capital has proposed acquiring all outstanding Surgery Partners shares not already owned by ...

Private equity firm Bain Capital plans to fully acquire Surgery Partners, one of the five largest operators of ambulatory surgery centers, for $3.2 billion.

BofA analyst Joanna Gajuk is moving to No Rating on Surgery Partners (SGRY) after Bain Capital made a non-binding proposal to buy the 61% stake ...

Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

With private equity circling and a modest premium on the table, will Bain's offer be enough to close the deal?